Skip to content
Richard Peek
Home
Contact Me
Publications
Richard Peek
←
Nonalcoholic fatty liver disease: The most common cause of abnormal liver enzymes in the U.S. population
A randomized, double-blind, placebo-controlied trial of subcutaneous etanercept (p75 souble tumor necrosis factor: FC fusion protein) in the treatment of moderate to severe Crohns’ disease
→
Maintenance infliximab (Remicade) is safe, effective and steroid-sparing in Crohn’s disease: Preliminary results from the accent i trial
Posted on
July 15, 2015
by
Stephen B. Hanauer, Gary R. Lichtenstein, J-F. Columbel, Lloyd Mayer, Stephan Schreiber, Daniel Rachmilewicz, Doug Wolf, Helmut Malchow, Michael Safdi, Brian Feagan, Allan Olson, Paul Rutgeerts
This entry was posted in Uncategorized. Bookmark the
permalink
.
←
Nonalcoholic fatty liver disease: The most common cause of abnormal liver enzymes in the U.S. population
A randomized, double-blind, placebo-controlied trial of subcutaneous etanercept (p75 souble tumor necrosis factor: FC fusion protein) in the treatment of moderate to severe Crohns’ disease
→
Links
Gastroenterology
MyVUMC
July 2015
S
M
T
W
T
F
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Aug »
Other websites
Etiological Studies of Gastric Carcinoma
H. pylori and Gastric Cancer
